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DC and AC magnetic fields increase neurite
outgrowth of SH-SY5Y neuroblastoma cells with
and without retinoic acid
Enad Abed Mahmood Alabed,abcd Martin Engel,ab Yusuke Yamauchi, *efg
Md. Shahriar A. Hossain*fh and Lezanne Ooi*ab
It has been suggested that electromagnetic fields could be used to differentiate neurons in culture but how
to do this is not clear. We investigated the effect of external magnetic fields (DC and AC MF) on neuronal
viability, differentiation, and neurite outgrowth of human SH-SY5Y neuroblastoma cells in vitro. A strong
low frequency DC MF or a weak AC MF improved retinoic acid-mediated neuronal differentiation and
increased neurite length, without any adverse effects on neuronal viability. Even in the absence of the
conventional differentiation factor, retinoic acid, DC and AC MF promoted neurite outgrowth. No
significant negative effect on cell viability was observed after MF exposure and the DC MF had greater
effects on neurite length and branch number than AC MF. Thus, we have identified a novel, simple and
cost-effective method that is easy to set up in any cell culture laboratory that can be used to efficiently
differentiate neuronal-like cells, using a DC MF without the need for expensive reagents. This research
provides a fresh approach to promote neurite outgrowth in a commonly used neuronal-like cell line
model and may be applicable to neural stem cells or primary neurons.
Introduction
Although it is almost impossible to avoid exposure to elec-
tromagnetic elds (EMF) in modern society, the effect of EMF
on neurogenesis and neuronal function remains unclear.
Thus, understanding the impact of EMF on neurons is
required. In addition, within the eld of cellular neurosci-
ence, a major challenge is generating cells that faithfully
recapitulate neuronal function. Many researchers use
neuronal-like cancer cell lines, such as human SH-SY5Y or
mouse Neuro2a neuroblastoma cells to provide relatively
easy access to a vast number of cells for analysis.1 These
proliferative cells are commonly differentiated into more
neuronal-like cells for functional analyses. To do this, cells
can be serum starved and/or treated with an agent, such as
retinoic acid (RA) or cyclic adenosine-30,50-monophosphate
(cAMP) to promote neuronal differentiation.1 Although not
much is known regarding the inuence of EMF on neuro-
genesis, enhancement of hippocampal neurogenesis in adult
mice can occur following exposure to the extremely low-
frequency electromagnetic eld (ELF-EMF).2 The impact of
the ELF-EMF on neural stem cells (NSCs) was shown by
exposing NSCs to EMF (50 Hz, 1 mT) for 1, 2 or 3 days for 4 h
per day, which considerably enhanced NSC proliferation and
maintenance.2 This ELF-EMF (50 Hz, 1 mT) increased cell
division and growth in various cell models3–5 and increased
proliferation of NSCs.6,7 An AC magnetic eld (AC MF) was
also tested for effects on the neurite outgrowth of PC-12D rat
pheochromocytoma cells. Whilst an electric eld of 0.2–115
mV m1 had no effect, a 2.2 or 4 mT 50 Hz AC MF stimulated
neurite outgrowth.8 Despite this, little information is avail-
able on the dynamics of EMF exposure on neuronal differ-
entiation. The application of an AC MF varies in orientation
and intensity, whereas the DC MF is unidirectional. SH-SY5Y
cells are a useful tool as a cell model for neuronal cells but
because they are a neuroblastoma cell line, under standard
cell culture conditions they continue to proliferate. To
promote their differentiation into more neuronal-like cells,
serum levels in the culture medium are reduced, in addition
to treatment with RA or expensive growth factors. This causes
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the cells to exit the cell cycle, extend neurites and become
terminally differentiated, expressing genes required for
neuronal function.1 Given the need for a simpler, more cost-
effective system, we thus investigated whether a high DC MF




The magnetic eld exposure system holder was designed to hold
an electromagnet (AC coil) and commercial N52 grade rare earth
(N52NdFeB) permanent magnets (for generating DC magnetic
eld) in close proximity, to obtain a uniform and controlled eld
gradient by varying the distance between the AC coil and the
permanent magnets. The holder was made from Perspex to ensure
safety while applying an AC current to the coil. The AC magnetic
eld exposure system had one circular copper coil (air core) with
400 turns and 10 layers; it was designed at Coast Electrical
Industries Pty Limited (Wollongong, Australia) to t inside the coil
holder, which was connected by a 300 mm long rod. The coil was
15 mm long 160 mm in diameter, and had an internal diameter
of 60 mm, as shown in Fig. 1. The wire used in the coil was
1.25 mm in diameter. The coil was connected to a function
generator (GFG 200/2100, Good Will Instrument, Taiwan) that
applied the frequencies and a power amplier (model YE5873H;
Sinocera Piezotronics, Inc.) to deliver an alternating current of up
to 3.6 A. However, to generate 1 mT of electromagnetic eld, we
applied only 0.36 A by the alternating current. This small current
did not produce any coil temperature and hence, thermal changes
to the cells. Two sizes (B6.4  5 and are B15.6  3 mm) of
N52NdFeB cylinder magnets were purchased from Chongqing
Seatrend Technology and Development. Co., Ltd. (Chongqing,
China) and 4 of the larger and 5 of the smaller magnets were
placed in parallel on the base of the magnetic system holder. The
strength of the MF intensity and frequency for both MFs were
assessed using a Gaussmeter (GM-2, AlphaLab, Inc.). This system
is just an updated design of our previous work.9
SH-SY5Y cell culture
SH-SY5Y neuroblastoma cells (94030304, Sigma) were cultured in
Dulbecco's modied Eagle's medium (DMEM)/F12 pH 7.4 (Life
Technologies, 12500096), supplemented with 10% foetal bovine
serum (FBS, Bovogen), and 1% penicillin/streptomycin (PS, Life
Technologies, 15140-122). The cells were kept in culture for up to
22 passages and maintained at 37 C in a 5% CO2 atmosphere.
Cells routinely underwent mycoplasma testing (MycoAlert, Lonza)
and were conrmed by Short Tandem Repeat proling.
Fig. 1 Magnetic exposure system experimental set up. It consists of a base containing two sizes of neodymium cylinder magnets, a base, a rod,
a plate holder and a coil holder.

























































































Neuronal differentiation and neurite analysis
The SH-SY5Y cells were plated in 96-well microplates (Greiner,
Sigma Aldrich, Sydney, Australia) at 5000 cells per well and then
cultured for 7 days. To induce differentiation of the cells, the
culture media was replaced with differentiation media (DMEM/
F12, 1% PS, 1% FBS, with or without 10 mM all-trans retinoic
acid (RA, R2625, Sigma Aldrich)) 24 h aer plating, followed by
100% media changes every 48 h. Dimethyl sulfoxide (DMSO)
was used as a vehicle control for the RA, and the vehicle control
medium was also changed every 48 h. SH-SY5Y cells were
treated with different intensities of AC or DC MF (either with or
without RA) for 2 days, starting 24 h aer plating, and the cells
were cultured until day 7 without any further exposure to EMF
from day 3. Cell images (four images per well of a 96-well plate)
were collected every day using an IncuCyte Zoom live imaging
system (Essen Bioscience, Michigan, USA) and analyzed by the
IncuCyte soware to acquire data on cell conuence (area
occupied by cells over the total area), neurite length (total
neurite length in mm mm2), and number of neurite branch
points (number per mm2). Controls were carried out using cells
cultured in 10% FBS media. Mean data were calculated from
technical replicates of 5 wells for the DC MF and 4 wells for the
AC MF. Mean data  SEM are shown from three independent
experimental repeats.
Cell viability
Cell viability was assessed by the AlamarBlue assay and
expressed as a percentage of control cells, as previously
described.10 In this study, the SH-SY5Y cells were plated into 96
– well microplates at 12 000 cells per well. The cells were
cultured in (DMEM)/F12 pH 7.4 supplemented with 10% foetal
bovine serum and 1% PS. On the rst day the cells were plated
a concentration of 12 000/well cells were seeded in the plates.
The cells were then treated with AC or DCMF every day for 2 or 3
days, starting 24 hours aer plating, depending on the experi-
mental conditions. The cells were cultured for 48 hours without
any further treatment with External MF. The uorescent
intensity of the reagent composed from AlamarBlue and the
cells was read on the plate reader (BMG-POLARstar Omega) 2
hours aer adding the viability reagent to the cells.
Statistics
The data are shown as the mean  standard error of the mean
(SEM) from at least 3 independent replicates. Statistical differ-
ences were identied aer conrming normal distribution, by
unpaired t-test, one-way or two-way repeated measures ANOVA
with Tukey's multiple comparisons post hoc, as appropriate.
Results
No signicant effect or negative impact of DCMF or AC MF on
cell viability
The experimental set up for the magnetic exposure system is
shown in Fig. 1. Prior to measuring the effect of DC and AC MFs
on neurite outgrowth we rst optimised the treatment condi-
tions to ensure there was no signicant negative effect on cell
viability by any of the treatments. To investigate the impact of
DC MF on cell viability, DC MF eld strengths were optimized
for different treatment times. The 100 mT, 4 h per day condition
for 2 days was the best condition for treating cells without any
negative impact on cell viability. There was no signicant
difference between cells treated with DC MF compared to the
control (t¼ 0.13, p¼ 0.90, unpaired t-test; Fig. 2A). Similarly, AC
MF conditions were also optimised and 100 Hz AC MF with
a constant magnetic eld strength of 1 mT for 4 h per day for 2
days was the best condition for treating cells without any
negative impact on cell viability (t ¼ 1.55, p ¼ 0.17; unpaired t-
test; Fig. 2B).
The effects of DC and AC MFs on neurite outgrowth
SH-SY5Y cells were treated with external magnetic elds under
either a DC or AC MF to investigate their impact on neurite
outgrowth. A range of MF strengths were tested to identify the
optimal conditions for treatment. The conditions outlined
below represent the best outcomes and involved using an MF
strength of 100 mT for the DC MF and 1 mT, 100 Hz for the AC
MF. The samples were treated with a 100 mT DC MF or a 1 mT,
100 Hz ACMF for 4 h per day for 2 days. Images of the cells were
collected every day until day 7. The effects of external MFs on
the SH-SY5Y cells were assessed, including measurement of cell
conuency, neurite length and number of neurite branch
points.
Treatment of cells with DC or AC MF for 4 h per day for 2 days
increased neurite length and neurite branch points
To assess the impact of MFs on neurite outgrowth, the cells
were grown in a medium containing 1% FBS supplemented
with RA every other day for the 7 day differentiation, and DMSO
was used as a vehicle control in these tests. Cells cultured with
10% FBS were used as a control and continued cycling, hence
conuence was increased compared with the reduced serum
conditions (Fig. 3A) and showed reduced/absent neurite exten-
sions (Fig. 3B and C). Reducing FBS to 1% FBS induced
neuronal differentiation and led to a reduction in conuence
(***p < 0.001). There were no signicant differences in cell
conuence for cells cultured under 1% FBS with any of the
Fig. 2 No negative impact of MF on cell viability. Cell viability was
assessed by AlamarBlue assay to investigate the impact of (A) a 100mT
DC MF and (B) a 1 mT, 100 Hz AC MF for 4 h per day over 3 days and is
shown as a percentage of non-MF-exposed controls. Results show
mean  SEM.

























































































treatments: vehicle (DMSO), RA, DC MF, AC MF, DC MF + RA,
AC MF + RA.
(i) DC or ACMF treatment in the presence of RA. There was
no signicant impact (overall two-way repeated measures
ANOVA F(3,8) ¼ 0.49, p ¼ 0.70) of either AC or DC MFs on cell
conuency (Fig. 3A). As expected, RA alone increased neurite
length compared to vehicle (DMSO), which became signicantly
different at day 4 of RA treatment (p < 0.01, Fig. 3B). DCMF + RA
and AC MF + RA treatment further increased neurite length
compared to RA alone, which became signicantly different
from RA alone from day 3 for both DCMF and ACMF (p < 0.001).
Neurites increased in length for both types of MF (overall two-
way repeated measures ANOVA F(3,8) ¼ 37.68, p < 0.0001). A
post hoc analysis revealed a signicant increase in neurite
length, starting from day 3 until day 7 for both DC and AC MFs
(p < 0.001 for days 3 to 7, Fig. 3B). Thus, the impact of treatment
on neurite length became signicant 24 h aer the last treat-
ment. The effect of DC MF + RA on days 3–7 led to a larger
increase in neurite length compared to RA alone and compared
to AC MF + RA treatment by day 4 (p < 0.001). Consistent with
the increases in neurite length, the number of neurite branch
points were also increased signicantly by DC MF + RA or AC
MF + RA compared to RA alone, from day 3 until day 7 (overall
two-way repeated measures ANOVA, F(3,8) ¼ 21.54, p ¼ 0.0001);
a post hoc analysis identied a signicant increase for days 3–7
for both ACMF + RA and DCMF + RA compared to RA alone (p <
0.05 for Days 3–7, Fig. 3C). The impact of the AC MF on neurite
outgrowth at days 3–7 was lower and more varied than the DC
MF treatment (Fig. 3C).
(ii) DC or AC MF treatment in the absence of RA. To assess
the effect of MF in the absence of RA, RA was omitted from
the cell culture medium and the effects of MF on neurite
length and number of branch points were assessed as above.
In these experiments MF was applied to cells cultured in
a medium containing 1% FBS. Both DC and AC MF had
similar effects on neurite outgrowth, even without RA.
Neither type of MF had an effect on cell conuency (overall
two-way repeated measures ANOVA, F(3,8) ¼ 11.34, p ¼ 0.0030,
Fig. 3A). Even in the absence of RA, DC MF and AC MF were
able to increase neurite length compared to RA, which
became signicantly different from RA alone at day 7 (p <
0.001). Neurite length increased signicantly with either type
of MF compared with control (overall two-way repeated
measures ANOVA, F(3,8) ¼ 16.92, p ¼ 0.0008). Post hoc anal-
ysis identied a signicant increase starting from day 5 until
day 7 for the DC MF (p < 0.05 for days 5–7, Fig. 3B), and from
day 6 to day 7 for the AC MF (p < 0.05 for days 6–7, Fig. 3B).
Thus, the effect of treatment became signicant 3 days aer
the last treatment day for DC and 4 days for AC. Conse-
quently, the DC MF was marginally better at increasing
Fig. 3 Exposure to DC and AC MFs for 4 h per day over 2 days increased neurite outgrowth and number of branch points in the presence or
absence of RA. (A) Percent confluence of the cultures was measured every day from day 1–7. Cells were cultured in 10% FBS (cycling conditions)
or 1% FBS to induce neuronal differentiation along with the treatments: vehicle (DMSO), RA, AC MF, DC MF, AC + RA, DC + RA. (B) Neurite length
(mm mm2) was measured every day from day 1–7 in the cells cultured in 10% FBS (cycling conditions) or 1% FBS with the treatments: vehicle
(DMSO), RA, AC MF, DC MF, AC + RA, DC + RA. (C) Neurite branch points (number per mm2) were assessed every day from day 1–7 in the cells
cultured in 10% FBS (cycling conditions) or 1% FBS with the treatments: vehicle (DMSO), RA, AC MF, DC MF, AC + RA, DC + RA.

























































































neurite length than the AC MF, with a signicant effect
earlier in the differentiation process. However, the effects of
AC MF were similar to DC MF by day 7 (Fig. 3B). Even in the
absence of RA, DC MF and AC MF were able to increase
neurite branch points compared to RA, which became
signicantly different to RA alone from day 5 for DC (p < 0.05)
and day 6 for AC (p < 0.05). Consistent with the ndings on
neurite length, the number of neurite branch points
increased signicantly compared to RA alone at days 5–7 for
DC while the impact of AC MF was not signicant until days
6–7 (overall two-way repeated measures ANOVA, F(3,8) ¼
6.347, p ¼ 0.02); post hoc analysis identied a signicant
increase starting on day 5 for DC MF (p < 0.05, Fig. 3C) and on
day 6 for AC MF (p < 0.05).
(iii) Comparision of DC or AC MF treatment with and
without RA. Neurite length in DC MF + RA was signicantly
increased compared to DC in the absence of RA between days 3–5
(p < 0.001) but by day 6 neurite length was not signicantly
different. Similarly, neurite length in ACMF + RA was signicantly
increased compared to AC in the absence of RA between days 3–5
(p < 0.001) but by day 6 neurite length was not signicantly
different, i.e. in the absence of RA either DC or AC MF was suffi-
cient to promote neurite length to a similar extent as DC MF + RA
or AC MF + RA by day 6. Consistent with the results on neurite
length, neurite branch points in DC MF + RA were signicantly
Fig. 4 IncuCyte images demonstrating the effects of treating SH-SY5Y cells for 4 hours per day over 2 days with AC and DC MF on neurite
outgrowth with and without RA. Images (A–D) are related to the presence of RA. Images (E–H) are associated with the absence of RA. All images
were collected on day 7. Yellow refers to the cell body and purple refers to the neurites. Scale bar is 300 mm.

























































































increased compared to DC in the absence of RA between days 3–5
(*p < 0.05, **p < 0.01, ***p < 0.001) but by day 6 branch points were
not signicantly different. Strikingly, by day 7 DC in the absence of
RA had increased branch points that were signicantly increased
compared to DC + RA (p < 0.01). Neurite branch points in ACMF +
RA were signicantly increased compared to AC in the absence of
RA between days 3–5 (*p < 0.05, **p < 0.01, ***p < 0.001) but by day
6 neurite branch points were not signicantly different. Thus by
day 7 DC MF in the absence of RA signicantly enhanced neurite
branch points compared to AC MF, DC MF + RA or AC MF + RA.
Together our data show that DCMF treatment alone thus provides
a simple, convenient method to promote neuritogenesis even in
the absence of RA.
(iv) Summary of the effect of DC and AC MF on neurite
outgrowth. Exemplary images of cell conuence and neurite
growth are shown in Fig. 4. AC or DC MF for 4 h per day for 3
days treatment was also tested with very similar effects on
neurite length, and branch points as for 2 days of treatment.
Exemplary images for the effects of these conditions on neurite
outgrowth and cell conuence in the presence and absence of
RA are shown in Fig. 5. The fold change in neurite length
following DC and ACMF treatment in the presence and absence
of RA is shown in Table 1. The fold change in number of neurite
branch points following DC and AC MF treatment in the pres-
ence and absence of RA is shown in Table 2.
Fig. 5 IncuCyte images illustrating the impact of treating SH-SY5Y cells for 4 hours per day over 3 days with DC and ACMF on neurite outgrowth
with and without RA. Images (A–D) are related to the presence of RA. Images (E–H) are associated with the absence of RA. All images were
collected on day 7. Yellow refers to the cell body and purple refers to the neurites. The scale bar is 300 mm.


























































































One study has reported that only AC MF exposure with and
without RA is effective for the cell growth. In this report, ELF
and extremely low AC MF (50 Hz–10 mT) has only been applied
in the presence and absence of RA for promoting the cell growth
in the human neuroblastoma cell line NB69.11 Together our data
suggest that the effects of DC MF on neuritogenesis were more
effective than AC MF. Moreover, whilst 3 days of treatment
rather than 2 days had no further benet with RA present,
treating the cells for 2 days rather than 3 days without RA was
more effective at promoting both neurite length and number of
branch points. Previous studies have reported that cell prolif-
eration in various cell models increased following ELF-EMF
exposure.4,5 Our cell viability results with AC MF treatment
agree with a study that utilised NSCs.2 In our study, SH-SY5Y
were treated with the same strength of AC MF (1 mT) but at
a higher frequency (100 Hz instead of 50 Hz). We also tested
50 Hz in our initial optimisation experiments but found that
100 Hz increased the effects on neurite growth (data not
shown).
An impact of MF on reactive oxygen species (ROS) has been
identied,12 but the inuence of MF appears to depend on
parameters including exposure time, frequency, intensity of
MF, and increasing or decreasing ROS levels within cells.12 It is
likely that altering MF exposure time affects ROS levels within
the cells, which could affect neuronal differentiation and
function.
Previous research has also reported that treating NSCs, PC12
pheochromocytoma cells, or dorsal root ganglion sensory
neurons with a very low frequency electromagnetic eld
increased neurite outgrowth,2,13,14 but an 1800 MHz radio-
frequency electromagnetic eld (RF-EMF) reduced the neurite
outgrowth of NSCs.12 Therefore, this study focused on the
impact that low frequency EMF exposure may have on the
neurite outgrowth of SH-SY5Y cells. Our ndings on SH-SH5Y
cells are thus compatible with studies on other neuronal
cells2,13,14 and suggest that the system we have described could
be used to promote neurite outgrowth or neuronal differentia-
tion of different types of neuronal cell lines, neural stem cells or
neurons.
A mechanism for inducing neurite outgrowth by exposure to
ELF-EMF has been suggested.2 In the developing brain, Ngn1
and NeuroD, which are proneuronal basic helix–loop–helix
(bHLH) transcription factors, promote neurite outgrowth of
NSCs.15,16 Expression of these proneural genes, which are crucial
Table 1 Comparison between the fold change in neurite length of MF compared to control in the 4 hours per day for 2 days and 4 hours per day
for 3 days conditions when RA is present and absent (mean  SEM, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)a
Time
4 hours per day for 2 days 4 hours per day for 3 days
Presence of RA Absence of RA Presence of RA Absence of RA
DC MF AC MF DC MF AC MF DC MF AC MF DC MF AC MF
Day 1 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
Day 2 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
Day 3 2.9  0.1*** 3.3  0.3**** n.s. n.s. 4.1  0.4**** 3.9  0.7**** n.s. n.s.
Day 4 2.5  0.1**** n.s. n.s. n.s. 2.5  0.1**** 1.4  0.1* n.s. n.s.
Day 5 3.1  0.1**** 2.2  0.2** 4.7  0.9* n.s. 3.6  0.4**** 2.5  0.3**** n.s. n.s.
Day 6 2.2  0.1**** 2.8  0.7**** 2  0.1*** 1.7  0.2* 2.2  0.2**** 3.2  0.4**** n.s. n.s.
Day 7 2.3  0.01**** 2.3  0.3**** 2.9  0.3**** 2.1  0.5**** 2.6  0.2**** 2.3  0.2**** 3.3  0.2**** 2.1  0.5*
a n.s. is non-signicant.
Table 2 Comparison between the fold change in neurite branch points of MF compared to control in the 4 hours per day for 2 days and 4 hours
per day for 3 days conditions when RA is present and absent (mean  SEM, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)a
Time
4 hours per day for 2 days 4 hours per day for 3 days
Presence of RA Absence of RA Presence of RA Absence of RA
DC MF AC MF DC MF AC MF DC MF AC MF DC MF AC MF
Day 1 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
Day 2 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
Day 3 3.1  0.2** 3.7  0.5**** n.s. n.s. 4.3  0.4**** 4.1  0.9**** n.s. n.s.
Day 4 2.8  0.1**** n.s. n.s. n.s. 2.9  0.1**** 1.6  0.1* n.s. n.s.
Day 5 3  0.3**** 2.1  0.3* n.s. n.s. 3.8  0.5**** 2.6  0.3**** n.s. n.s.
Day 6 2.2  0.06** 2.8  0.7**** 2.1  0.1* n.s. 2  0.2*** 3.1  0.3**** 2  0.04* n.s.
Day 7 2.2  0.1**** 2.3  0.5**** 3.3  0.3**** 2  0.5** 2.5  0.2**** 2.2  0.1**** 3.8  0.4**** n.s.
a n.s. is non-signicant.

























































































for neuronal differentiation and neurite outgrowth, increased
aer the exposure of NSCs to a 1 mT, 50 Hz AC MF for 4 h per
day over 3 days, but exposure to 1800 MHz (RF-EMF) resulted in
downregulation of these genes, thereby decreasing neurite
outgrowth of NSCs.17 Previous studies also reported that the
mammalian transient receptor potential channel (TRPC) 1
contributed to neuronal differentiation and proliferation of
NSCs and participated in regulating neurite outgrowth.18,19
TRPC1 enhanced neurite outgrowth in PC12 cells, whereas
TRPC5 decreased it.20 Furthermore, exposure of NSCs to an EMF
increased intracellular Ca2+ by signicantly up-regulating the
gene expression of TRPC1, and Tuj1+ neurons that differenti-
ated from NSCs, expressed TRPC1, suggested that TRPC1
promotes neurite outgrowth.2
A relatively complicated set up is required to apply an AC
electromagnetic eld to cell cultures. Instruments such as
a coil, power amplier, and function generator are more
expensive than permanent magnets, and they can become
damaged when connected to an electricity supply. The perma-
nent magnets used as the DC MF source in this study are safer
than electromagnetic devices because they are not connected to
a power source. Therefore, DC MFs are simpler to set up, safer,
and more cost-effective (as they are consumable-free) than AC
electromagnetic equipment or consumables such as retinoic
acid and growth factors. Permanent magnets can also produce
stronger magnetic elds than AC electromagnetic equipment
because they can reach 300 mT or higher, depending on the size
of the magnet.
Previous studies have investigated the effect of a DC electric
eld using different cell models.21–23 A DC electric eld
enhanced directional migration and stem cell differentiation,
facilitated by calcium inux following DC electric eld expo-
sure.23 Thus, the mechanism for inducing neurite outgrowth by
a DCMF could be the same as for an ACMF and may induce the
expression of proneuronal genes, such as NeuroD and Ngn1,
which are crucial for neuronal differentiation and neurite
extension. DC MF, as for AC MF,17 may also increase the gene
expression of TRPC1 to facilitate Ca2+ inux. With regards to the
reason behind the increased effectiveness of DC over AC and the
higher variability in the results for AC MF, we observed that the
AC MF increased the temperature of the surrounding area close
to the equipment, whereas the DCMF did not, and we speculate
that this led to a marginal adverse effect on neurite outgrowth
(length and branch points, observed as a reduction in both
neurite length and branch points aer treatments, these
recovered aer 5 days).
RA induces neuronal differentiation and limits the prolifer-
ation of neuronal-like cell lines and neural progenitors;24
however, long periods of differentiation (beyond 8–10 days) with
RA are problematic due to the accumulation of proliferating
cells.25 Since the DC MF promoted neurite extension of neuro-
blastoma cells in the absence of RA, a DC MF may be able to
replace RA in experiments beyond 8–10 days or potentially
completely. RA efficiency of neuronal differentiation is also
variable in different cell types. Notably, the efficiency of neural
differentiation using RA in induced pluripotent stem cells was
reported to bemuch lower than in embryonic stem cells.26Much
remains unknown about the effects of MF on neurons and other
cells in vivo. Transcranial magnetic stimulation (TMS) is
becoming widely used clinically (as well as experimentally) to
alter neural function and repair neuronal signalling pathways
for diverse neurological conditions. Our system could be
adapted to uncover the mechanisms by which magnetic stim-
ulation promotes neuritogenesis or neural repair. Harnessing
MFs for therapeutic effects in vivo is thus an important area of
research. Consequently, testing neuronal differentiation in
longer experiments, in pluripotent stem cells, and in vivo will be
important for future research.
Conclusions
We have identied a simple, cost-effective method of promoting
neuronal differentiation of SH-SY5Y cells. Applying external
magnetic elds (either DC or AC), with or without the presence
of retinoic acid, increased neurite length and the number of
neurite branch points without negatively affecting cell viability
or cell conuence. In the absence of RA, both types of magnetic
elds signicantly increased neurite outgrowth following
treatment for 4 h per day for two days. Under the parameters
used here DC MF was more effective at promoting neurite
outgrowth than AC MF.
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